Data Published in Ocular Oncology and Pathology Demonstrates Highly Accurate Performance of DecisionDx®-UMSeq for Patients with Uveal Melanoma
DecisionDx-UMSeq is Castles 7-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to uveal melanoma.
- DecisionDx-UMSeq is Castles 7-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to uveal melanoma.
- DecisionDx-UM is the standard of care in the management of newly diagnosed UM in the majority of ocular oncology practices in the United States.
- The study titled, Analytical validation and performance of a 7-gene next-generation sequencing panel in uveal melanoma, was recently published in the peer-reviewed journal Ocular Oncology and Pathology.
- Elevated expression of PRAME has been associated with an increased risk of metastasis in patients with uveal melanoma.